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Tuberculosis
 Causative agent is Mycobacterium tuberculosis
 Strikes in the lungs and slowly dissolves the 
tissues
 Diagnosed via Sputum Test, Tuberculin Skin 
Test, or TB Blood Test
 Easily spread by airborne transmission through 
coughing or sneezing
Implant
MacNeil A, Glaziou P, Sismanidis C, Maloney S, Floyd K. Global Epidemiology of Tuberculosis and Progress Toward 
Achieving Global Targets — 2017. MMWR Morb Mortal Wkly Rep 2019;68:263–266.
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Future
The bacterium Mycobacterium tuberculosis, also referred to as MTb, infects individuals 
in latent, active and resistant forms. There are recommended regimens for the delivery 
of established antibiotics to infected individuals. These regimens focus on the oral 
administration and involve relatively large doses that often result in significant side 
effects. This invention is a biodegradable implant composed primarily of an inert 
saturated fatty acid, namely stearic acid. The antibiotic is incorporated into the stearic 
acid matrix along with other constituents. The composition also includes a salt to 
regulate the release rate of the antibiotic, a metal-stearate structure to provide 
additional toxicity against MTb, ascorbic acid, and unsaturated fatty acids in low 
concentrations. As the fatty acid implant dissolves it forms a micelle that encapsulates 
the antibiotic. The micelle is transported to the infected area by serum and, since it is a 
primary energy source for the bacterium, is consumed. The antibiotic is hidden in the 
matrix (micelle). The biodegradable implant, which can be inserted as a single 
component or a as spheres of different sizes (i.e. micrometer) does not have to be 
removed. 
Figure 2. Annual tuberculosis incidence(per 100,000), by region–
worldwide in 2017
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Strain Drug Side Effects
Active • Isoniazid
• Rifampin
• Pyrazinamide
• Ethambutol
• Streptomycin
• Hepatitis
• Jaundice
• Dizziness and loss of 
balance
• Nausea and vomiting
• Seizure
• HallucinationsLatent • Rifampin
• Isoniazid
• Isoniazid and 
Rifapentine
Resistant • Capreomycin
• Fluoroquinolones
• Nephrotoxicity
• Renal Damage
Existing Drugs Our Implant
• Expensive
• Oral administration
• Large dosages
• Must be removed
• Cost effective
• Biodegradable
• Lower dosage
• Does not have to be removed
Vial 
Composition
Hour 1 Hour 2 Hour 3 Hour 4
50 mls RO 
water
1 g CuCl2*2H2O
0.01 gram ETH
50 mls RO water
1 g CuCl2*2H2O
1 gram INH
0.5 gram Stearic 
acid
Composition Significance
Amino Acids Essential nutrients for MTb survival.
Cholesterol Survival of MTb is based on the 
accumulation of cholesterol
Copper Complexes Used to increase water solubility, block 
unwanted hydrogen bonding, increase 
structural rigidity and help to escape 
detection in the immune system
Vitamin C Used to protect the implant from redox 
reaction that can naturally occur in human 
serum
Stearic Acid Mimics the cell membrane 
of Mycobacterium tuberculosis
PEG 3350 Used for solubility, aggregate formation and 
release rate
Sodium Acetate Encourages dissolution rate
Oleic Acid Low toxicity decrease the survival rate
Sodium Chloride Strong electrolyte impacts rate of release
Figure 3. Composition of the implant
Figure 1. Computer generated  image 
of drug-resistant Mycobacterium 
tuberculosis
Name of 
acid
Type of 
Fatty Acid
# of 
Carbons
Melting 
point (°C)
Water 
Solubility 
(mg/L)
Oleic Acid Unsaturated 18 13.4 Insoluble
Stearic Acid Saturated 18 69.3 0.597
Electrolyte 
Name
Type 
Electrolyte
Function
Sodium Chloride 
(NaCl)
Strong • Regulates 
drug release 
rate
Sodium Acetate 
(NaAc)
Strong • Increase 
water 
solubility and 
faster 
release rate
Calcium Carbonate 
(CaCO3)
Weak • Dissolves at 
slower rate
• Longer drug 
release rate
• Negative 
effects
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Composition: Stearic Acid Composition: Stearic Acid and Sodium Acetate
Figure 4. Conductivity comparison of Stearic Acid (left) vs Stearic Acid and Sodium Acetate 
(right). Hundreds of measurements were made by our group, this is representative data.
Experimental Data 
Figure 5. Stearic acid is used as a matrix to contain a dozen molecular species used to 
attack/weak Mycobacterium tuberculosis. Tablets and dust of different sizes and shapes have been used to 
date. A tablet containing the medicinal species will be emerged in water for almost a month, and then molecular 
species will slowly leach out into the aqueous phase. This replicates what would take place in in vivo.
Mechanism of Action
Currently writing a patent application. Experiments planned for spring include a complex 
series of measurements at THE NATIONAL HIGH FIELD MAGNET LAB to study the release 
rate of the different components.
